WPC
ROIV icon

Wedmont Private Capital’s Roivant Sciences ROIV Stock Holding History

Wedmont Private Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Sell
15,587
-230
-1% -$6.8K 0.02% 517
2026
Q1 		$446K Buy
15,817
+355
+2% +$9.12K 0.01% 535
2025
Q4 		$340K Buy
15,462
+2,247
+17% +$44.3K 0.01% 609
2025
Q3 		$213K Buy
13,215
+2,136
+19% +$26.4K 0.01% 742
2025
Q2 		$124K Buy
+11,079
New +$120K 0.01% 729
2025
Q1 		– Sell
-11,295
Closed -$120K – 757
2024
Q4 		$120K Buy
+11,295
New +$134K 0.01% 690

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wedmont Private Capital's ROIV Position: Q2 2026 in Review

Wedmont Private Capital reduced its Roivant Sciences (ROIV) stake by 1.5% in Q2 2026, selling an estimated $6.8K and leaving 15,587 shares worth $561K. The position accounts for 0.02% of the portfolio, ranked #517.

Wedmont Private Capital first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Wedmont Private Capital held 15,587 shares of Roivant Sciences worth $561K as of Q2 2026.
  • Wedmont Private Capital sold 230 Roivant Sciences shares in Q2 2026, an estimated $6.8K.
  • Roivant Sciences made up 0.02% of Wedmont Private Capital's portfolio in Q2 2026, its #517 holding.
  • Wedmont Private Capital first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.